The national AHIP (America’s Health Insurance Plans) conference took place earlier this week. It provided important information regarding prescription drug prices and payer-specific issues. Keynote speaker Sarah Emond of ICER shared her thoughts on pricing policy and what changes may come this year and beyond. The new administration is expected to bring changes to prescription drug pricing legislation.
“This week’s health insurance industry policy conference provides an opportunity to gain insights on the prospects of drug pricing reforms following a week that highlighted the difficulty Democrats likely would face if they try to pass a second budget reconciliation bill later this year that many believe is the most likely vehicle for major drug pricing legislation.” Read more here.
(Source: John Wilkerson, Inside Health Pricing, 3/8/21)